Science
Harvard Professor-Led Company Says It Reconstructed Genome of Extinct Tasmanian Tiger
Colossal Laboratories and Biosciences, a company co-founded by Harvard professor George M. Church, announced last week that it had reconstructed the genome of the extinct Tasmanian tiger with more than 99.9 percent accuracy — the most complete ancient genome of its kind.
AI Is Changing Healthcare. Harvard Medical School Is Following Suit.
The Harvard Medical School started offering a month-long introductory course on AI in healthcare for students on its Health Sciences and Technology track — the first of its kind offered at a medical school.
European Court Invalidates Harvard Biotech Patent in Three Countries
A top European court ruled against Harvard last week in a patent dispute against biotech company NanoString Technologies, invalidating one of the University’s two disputed patents in three European countries.
Kip Thorne, 2017 Nobel Laureate, Talks Black Holes During Inaugural Hawking Lecture
Hundreds packed Science Center Hall B to watch Kip S. Thorne, a professor of theoretical physics at Caltech and a 2017 Nobel Prize laureate, discuss black holes and wormholes during the inaugural Hawking Lecture on Friday.
Cerebellum Only Necessary for Some Muscle Memory, Harvard Researchers Find
In an August study, researchers at the Harvard School of Engineering and Applied Sciences discovered a new distinction between long and short-term motor memories — a class of memories developed through repeated physical movements.
Broad Institute of MIT and Harvard Lays Off 87 Workers in Restructuring Effort
The Broad Institute of MIT and Harvard announced on Oct. 10 that it laid off 87 employees as part of a strategic restructuring.
‘Share the Universe’: Harvard Astronomy Club Holds Rare Comet Viewing
Dozens of students gathered at Harvard’s Loomis-Michael Observatory on Thursday and Friday for a rare viewing of Comet Tsuchinshan-ATLAS, a “naked-eye visible comet” that researchers say is unlikely to return for at least 80,000 years.
Human and Evolutionary Biology Dept. Holds Focus Groups on Renaming Concentration
Harvard’s Human Evolutionary Biology department is holding focus groups to seek student feedback on potential name options.
Harvard-Led Researchers Are Creating an Air Quality Sensor Inspired By Dog Noses
Researchers led by Harvard School of Engineering and Applied Sciences professor Joanna Aizenberg are developing a new air quality sensor inspired by a dog’s nose that promises more specificity than existing products.
Harvard’s Wyss Institute Gives Startup License to Use Newly-Developed Biomaterials
Attivare Therapeutics, a startup founded by researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering, received a license from the Wyss Institute to use biomaterials developed at Harvard to create treatments for tumors that do not respond to existing immunotherapies.
Harvard Museum of Natural History Hosts National Fossil Day
The Harvard Museum of Natural History welcomed visitors on Sunday for its third annual National Fossil Day event since the Covid-19 pandemic, allowing children and adults to learn about paleontology by interacting with artifacts from the museum's collections.
Brigham and Women's Hospital Researchers Find Nasal Spray Protects Against Respiratory Illnesses
Researchers found that a drug-free nasal spray protected against airborne respiratory illnesses — including Covid-19, influenza, viruses, and pneumonia — in a preclinical study published by Harvard Medical School-affiliated Brigham and Women’s Hospital on Sept. 24.
The Nobel Laureate Harvard Didn’t Want
On Monday, one Harvard professor was awarded the Nobel Prize in Medicine. But if Victor R. Ambros had not been denied tenure more than three decades earlier, it could have been two.
Canadian Biotech Company to Supply MDMA for McLean Hospital Clinical Trial
Toronto-based MDMA manufacturer PharmAla Biotech signed a contract to supply researchers at McLean Hospital, an HMS-affiliated psychiatric teaching hospital, with the drug for a pending clinical trial, PharmAla announced in a Oct. 2 press release.
HMS Researchers Introduce AI Tool for Drug Repurposing
Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model which is able to suggest new treatment applications of existing drugs using neural networks.
